(IT) Gartner - Overview
Research, Conferences, Consulting
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | -4.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.91 |
| Alpha | -73.84 |
| Character TTM | |
|---|---|
| Beta | 0.889 |
| Beta Downside | 0.794 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.80% |
| CAGR/Max DD | -0.23 |
Description: IT Gartner December 19, 2025
Gartner, Inc. (NYSE:IT) is a global research and advisory firm that monetizes its expertise through three primary segments: Research (subscription-based access to reports, benchmarks, and expert networks), Conferences (in-person and virtual events for executive learning and networking), and Consulting (custom analysis and implementation support for IT cost optimization, digital transformation, and sourcing). The company operates across North America, Europe, the Middle East, Africa, and other international markets, with its corporate headquarters in Stamford, Connecticut.
According to Gartner’s FY 2023 filing, total revenue reached $5.1 billion, up ~5 % year-over-year, driven primarily by a 7 % increase in Research subscription revenue and a 3 % rise in Consulting services. The firm posted an operating margin of roughly 22 %, reflecting the high-margin nature of subscription and advisory businesses, while free cash flow generated $1.1 billion, supporting ongoing share buybacks and dividend growth.
Key macro-economic drivers for Gartner include sustained growth in corporate IT spending (projected 4-5 % CAGR through 2027) and accelerated digital transformation initiatives prompted by cloud migration and AI adoption. Additionally, cost-containment pressures in enterprise IT budgets elevate demand for Gartner’s cost-optimization and sourcing advisory services, positioning the company to benefit from both top-line expansion and higher-margin consulting engagements.
For a deeper, data-driven valuation perspective, you may find ValueRay’s analyst notes on Gartner useful.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 885.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 0.61 > 1.0 |
| NWC/Revenue: -11.29% < 20% (prev 1.30%; Δ -12.59% < -1%) |
| CFO/TA 0.18 > 3% & CFO 1.33b > Net Income 885.7m |
| Net Debt (1.42b) to EBITDA (1.27b): 1.11 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.0m) vs 12m ago -3.82% < -2% |
| Gross Margin: 68.17% > 18% (prev 0.68%; Δ 6750 % > 0.5%) |
| Asset Turnover: 85.59% > 50% (prev 78.24%; Δ 7.35% > 0%) |
| Interest Coverage Ratio: 19.91 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 53.8m) |
Altman Z'' 4.22
| A: -0.10 (Total Current Assets 2.76b - Total Current Liabilities 3.49b) / Total Assets 7.25b |
| B: 0.89 (Retained Earnings 6.48b / Total Assets 7.25b) |
| C: 0.14 (EBIT TTM 1.07b / Avg Total Assets 7.55b) |
| D: 0.96 (Book Value of Equity 6.44b / Total Liabilities 6.69b) |
| Altman-Z'' Score: 4.22 = AA |
Beneish M -3.07
| DSRI: 0.86 (Receivables 1.18b/1.31b, Revenue 6.46b/6.14b) |
| GMI: 0.99 (GM 68.17% / 67.78%) |
| AQI: 1.17 (AQ_t 0.55 / AQ_t-1 0.47) |
| SGI: 1.05 (Revenue 6.46b / 6.14b) |
| TATA: -0.06 (NI 885.7m - CFO 1.33b) / TA 7.25b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of IT shares?
Over the past week, the price has changed by -2.78%, over one month by -10.96%, over three months by -10.57% and over the past year by -58.35%.
Is IT a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the IT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 284.2 | 25.8% |
| Analysts Target Price | 284.2 | 25.8% |
| ValueRay Target Price | 191 | -15.5% |
IT Fundamental Data Overview January 29, 2026
P/E Forward = 17.5747
P/S = 2.72
P/B = 30.6387
P/EG = 1.99
Revenue TTM = 6.46b USD
EBIT TTM = 1.07b USD
EBITDA TTM = 1.27b USD
Long Term Debt = 2.46b USD (from longTermDebt, last quarter)
Short Term Debt = 94.2m USD (from shortTermDebt, last quarter)
Debt = 2.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 18.99b USD (17.57b + Debt 2.85b - CCE 1.43b)
Interest Coverage Ratio = 19.91 (Ebit TTM 1.07b / Interest Expense TTM 53.8m)
EV/FCF = 15.62x (Enterprise Value 18.99b / FCF TTM 1.22b)
FCF Yield = 6.40% (FCF TTM 1.22b / Enterprise Value 18.99b)
FCF Margin = 18.82% (FCF TTM 1.22b / Revenue TTM 6.46b)
Net Margin = 13.71% (Net Income TTM 885.7m / Revenue TTM 6.46b)
Gross Margin = 68.17% ((Revenue TTM 6.46b - Cost of Revenue TTM 2.06b) / Revenue TTM)
Gross Margin QoQ = 68.88% (prev 68.47%)
Tobins Q-Ratio = 2.62 (Enterprise Value 18.99b / Total Assets 7.25b)
Interest Expense / Debt = 0.57% (Interest Expense 16.3m / Debt 2.85b)
Taxrate = 49.11% (34.1m / 69.5m)
NOPAT = 545.1m (EBIT 1.07b * (1 - 49.11%))
Current Ratio = 0.79 (Total Current Assets 2.76b / Total Current Liabilities 3.49b)
Debt / Equity = 5.12 (Debt 2.85b / totalStockholderEquity, last quarter 556.6m)
Debt / EBITDA = 1.11 (Net Debt 1.42b / EBITDA 1.27b)
Debt / FCF = 1.17 (Net Debt 1.42b / FCF TTM 1.22b)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.73% (Net Income 885.7m / Total Assets 7.25b)
RoE = 71.62% (Net Income TTM 885.7m / Total Stockholder Equity 1.24b)
RoCE = 28.96% (EBIT 1.07b / Capital Employed (Equity 1.24b + L.T.Debt 2.46b))
RoIC = 14.74% (NOPAT 545.1m / Invested Capital 3.70b)
WACC = 7.95% (E(17.57b)/V(20.42b) * Re(9.19%) + D(2.85b)/V(20.42b) * Rd(0.57%) * (1-Tc(0.49)))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.57%
[DCF Debug] Terminal Value 78.73% ; FCFF base≈1.24b ; Y1≈1.28b ; Y5≈1.44b
Fair Price DCF = 332.1 (EV 25.36b - Net Debt 1.42b = Equity 23.94b / Shares 72.1m; r=7.95% [WACC]; 5y FCF grow 3.16% → 2.90% )
EPS Correlation: -16.94 | EPS CAGR: -38.95% | SUE: -1.68 | # QB: 0
Revenue Correlation: 81.47 | Revenue CAGR: 4.20% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.07 | Chg30d=-0.012 | Revisions Net=-4 | Analysts=13
EPS next Year (2026-12-31): EPS=13.46 | Chg30d=-0.004 | Revisions Net=+0 | Growth EPS=+5.3% | Growth Revenue=+3.3%